Loading clinical trials...
Loading clinical trials...
To assess the safety and efficacy of SPD489 low-dose and high-dose treatment groups to placebo when given as adjunctive therapy to antipsychotic medication in clinically stable adults with persistent ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shire
NCT07356765 · Schizophrenia, Negative Symptoms of Schizophrenia
NCT06793995 · Alzheimer's Disease Psychosis, Parkinson Disease Psychosis, and more
NCT04620460 · Negative Symptoms of Schizophrenia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions